MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Antidepressants Associated with Worsening Dyskinesia in Parkinson’s Disease

    JV. Costa, EF. Muricy, FS. Brito, GS. Nunes, SC. Baran, GV. de Vasconcelos, CF. Do Nascimento, NS. Dos Santos, JX. Oliveira, ME. Vassoler, FG. Nascimento, AM. Guerra, RB. Kauark (Salvador, Brazil)

    Objective: This case report aims to highlight the impact of increasing venlafaxine dose on the worsening of dyskinesias and the onset of ocular dyskinesia³ and…
  • 2025 International Congress

    Comparing the Impact of Levodopa versus Pramipexole on Eye-Tracking Parameters in Treatment-Naïve Parkinson’s Disease: A Longitudinal Study

    Z. Kosutzka, L. Hapakova, I. Straka, A. Kusnirova, M. Minar (Bratislava, Slovakia)

    Objective: To investigate the differential effects of levodopa versus pramipexole on eye-tracking parameters in treatment-naïve patients with Parkinson's disease. Background: Parkinson's disease (PD) is characterized…
  • 2025 International Congress

    Comparative Safety of Different Routes of Apomorphine Administration in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    A. Al Midani, A. Ahmad, O. Razouk, L. Mohamedali, M. Al Khalidi, B. Al Karam, A. Khater (Sharjah, United Arab Emirates)

    Objective: To assess the safety profiles of inhaled, sublingual, and subcutaneous apomorphine in patients with Parkinson’s disease (PD). Background: Apomorphine is a direct-acting D1/D2 agonist…
  • 2025 International Congress

    Glucagon Like Peptide-1 (GLP-1) Receptor Agonists for Parkinson’s Disease: An Updated Systematic Review and Meta-Analysis

    F. Alnajjar, A. Abunamoos, M. Mustafa, Y. Aljazi, K. Moghib, A. Rababah, M. Alghaniem (Amman, Jordan)

    Objective: To evaluate the efficacy and safety of GLP-1 receptor agonists in Parkinson's disease (PD) by adding new 2025 randomized controlled trial (RCT) data, and…
  • 2025 International Congress

    Synchronized High Frequency Neural Oscillations as a Biomarker for Differentiating the Internal from the External Segment of the Globus Pallidus in Parkinson’s Disease

    J. Aman, K. O'Neill, S. Safo, M. Hill, S. Alberico, R. Cole, L. Johnson, J. Wang, K. Domingo, L. de Almeida, S. Cooper, D. Darrow, R. Mcgovern Iii, M. Park, L. Eberly, J. Vitek (Minneapolis, USA)

    Objective: To assess whether using high frequency oscillations (HFO; 150-350 Hz) or beta band oscillations (13-30 Hz) can objectively differentiate the external from the internal…
  • 2025 International Congress

    Utilization of Phosphorylated Alpha-Synuclein Skin Biopsy Testing in a Movement Disorders Center

    S. Anis, A. Kundrick, C. Piccinin, T. Lopez-Gonzalez, D. Dos Santos, H. Fernandez (Cleveland, USA)

    Objective: To describe the utilization patterns of skin biopsy for phosphorylated alpha-synuclein (P-syn) aggregation obtained from three sites (posterior cervical, distal thigh, distal leg) and…
  • 2025 International Congress

    Three Biopsies Optimizes Test Performance for the Detection of Cutaneous Phosphorylated Alpha-Synuclein

    T. Levine, B. Bellaire, H. Khona, R. Freeman, C. Gibbons (scottsdale, USA)

    Objective: To review two independent data sets to define the test performance of skin biopsies for the detection of P-SYN and peripheral nerve degeneration in…
  • 2025 International Congress

    Eye tracking identifies biomarkers predicting Parkinson’s disease before motor symptom onset

    A. Yoritaka, M. Ando, S. Nakayama, K. Fusegi, S. Nojiri, A. Tozuka, Y. Wang, W. Urasaki, N. Hattori (Saitama, Japan)

    Objective: To investigate eye movement changes as an early motor biomarker of Parkinson’s disease (PD) in patients with REM sleep behavior disorder (RBD). Background: RBD…
  • 2025 International Congress

    Daily Activity Analysis of Parkinson’s Disease Using Machine Learning with 3D Poses

    KD. Kim, S. Lyu, T. Dunn (Durham, USA)

    Objective: This study aims to find a digital behavioral marker Parkinson’s disease (PD) in activities of daily living via machine learning (ML) analysis of 3D…
  • 2025 International Congress

    Tracking Cognitive Decline and Understanding Study Dropout in PD-GBA

    M. Bode, C. Pauly, S. Jónsdóttir, C. Schulte, B. Becker, B. Roeben, I. Wurster, S. Lerche, W. Poewe, R. Krüger, K. Brockmann, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: Analyze which cognitive functions are affected in PD_GBA+, and which factors are linked to dropout risk. Background: People with Parkinson's disease (PD) who carry…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley